Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Barnes Sees FY22 Adj. EPS $1.90-$2.05 vs $2.16 Est.; Sees Organic Net Sales Growth 5-6%

By Bill Haddad
July 29, 6:32 AM
Barnes now expects 2022 organic sales growth of 5% to 6% and negative foreign exchange of approximately 3%. Adjusted operating margin is now forecasted to be in the range

B

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance

By Vandana Singh
July 29, 6:04 AM
AstraZeneca Plc (NASDAQ:AZN) Q2 profits fell sharply on ballooning costs linked to its Alexion takeover. The net profit was down…

AZN

Read More
1 minute read
  • After-Hours Center
  • Earnings
  • Guidance
  • Movers
  • News
  • Trading Ideas

Five9 Clocks Solid Q2 Results, Issues Upbeat Q3, FY22 Outlook

By Akanksha Bakshi
July 28, 5:48 PM
Provider of cloud contact center software, Five9 Inc (NASDAQ:FIVN) reported a second-quarter revenue increase of 32% year-over-year to $189.38 million, beating…

AMZN

Read More
1 minute read
  • Guidance
  • News

Apple CFO Says Expects Services Revenue To Grow But Decelerate From June Quarter

By Michael Horton
July 28, 5:27 PM
-Reuters

AAPL

Read More
1 minute read
  • Guidance
  • News

Apple CFO Says Not Providing Revenue Guidance

By Michael Horton
July 28, 5:26 PM
-Reuters

AAPL

Read More
1 minute read
  • After-Hours Center
  • Earnings
  • Guidance
  • Movers
  • News
  • Trading Ideas

Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook

By Akanksha Bakshi
July 28, 4:54 PM
Edwards Lifesciences Corp (NYSE:EW) reported second-quarter sales of $1.37 billion, flat compared to 2Q21, missing the consensus of $1.4 billion.…

EW

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Guidance
  • Markets
  • News
  • Psychedelics

Hemp Company Offers Ketamine-Assisted Therapy To Employees As A Healthcare Benefit

By Lara Goldstein
July 28, 3:57 PM
Plant-based wellness product provider HempLucid is advancing medically supervised ketamine-assisted therapy (KAP) as an employee healthcare benefit.

TSX:NUMI

Read More
1 minute read
  • Earnings
  • Guidance
  • Movers
  • News
  • Trading Ideas

Fortive Stock Gains Post Q2 Beat

By Akanksha Bakshi
July 28, 3:30 PM
Fortive Corp (NYSE:FTV) reported second-quarter sales growth of 10.9% year-over-year to $1.46 billion and core sales +9%, beating the consensus of…

FTV

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Smith & Nephew Shares Fall On Lower Margins As Cost Headwinds Hit Q2 Profit

By Vandana Singh
July 28, 3:30 PM
Smith & Nephew Plc (NYSE:SNN) reported Q2 revenue of $1.29 billion, up 1.2% on an underlying basis but down 3.1%…

SNN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Price Target
  • Trading Ideas

Teladoc Health’s Revised Outlook ‘Implies More Downside’ According To This Analyst

By Vandana Singh
July 28, 3:16 PM
Needham downgraded Teladoc Health Inc (NYSE:TDOC) to Hold following the company’s revised FY22 outlook, which now assumes the low end of…

TDOC

Posts pagination

Previous 1 … 621 622 623 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service